Shuttle Pharmaceuticals Holdings, Inc. SHPH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 40.86% | 81.16% | 92.83% | 65.23% | 142.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.01% | 20.73% | 54.84% | 51.43% | 103.33% |
| Operating Income | 4.01% | -20.73% | -54.84% | -51.43% | -103.33% |
| Income Before Tax | 15.50% | -3.39% | -28.18% | -16.53% | -68.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 15.50% | -3.39% | -28.18% | -16.53% | -68.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.50% | -3.39% | -28.18% | -16.53% | -68.75% |
| EBIT | 4.01% | -20.73% | -54.84% | -51.43% | -103.33% |
| EBITDA | 17.30% | -17.64% | -51.17% | -51.49% | -103.51% |
| EPS Basic | 85.62% | 63.63% | -58.69% | -- | -- |
| Normalized Basic EPS | 84.58% | 62.85% | -60.22% | -- | -- |
| EPS Diluted | 86.90% | 67.48% | -29.05% | -- | -- |
| Normalized Diluted EPS | 84.58% | 62.85% | -60.22% | -- | -- |
| Average Basic Shares Outstanding | 1,070.32% | 1,763.44% | 3,215.74% | -- | -- |
| Average Diluted Shares Outstanding | 1,070.32% | 1,763.44% | 3,215.74% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |